Literature DB >> 2712203

Liver resection without blood transfusion.

J A Ryan1, D J Faulkner.   

Abstract

A personal series of 58 liver resections was reviewed to identify technical factors minimizing blood transfusions. We identified a concept of vascular isolation prior to parenchymal division (VIP) which used singularly or in combination the following methods of vascular control: parenchymal compression, Pringle maneuver, hepatic venous tourniquet, hilar division, hepatic vein division, and Heaney maneuver. VIP significantly decreased the need for transfusion; of 34 patients with VIP only 2 (6 percent) required transfusion, whereas of 24 patients without VIP, 18 (75 percent) required transfusion (p less than 0.001).

Entities:  

Mesh:

Year:  1989        PMID: 2712203     DOI: 10.1016/0002-9610(89)90637-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Major liver resection, systemic fibrinolytic activity, and the impact of tranexamic acid.

Authors:  Paul J Karanicolas; Yulia Lin; Jordan Tarshis; Calvin H L Law; Natalie G Coburn; Julie Hallet; Barto Nascimento; Janusz Pawliszyn; Stuart A McCluskey
Journal:  HPB (Oxford)       Date:  2016-10-18       Impact factor: 3.647

3.  Stress response to laparoscopic liver resection.

Authors:  Kazuki Ueda; Patricia Turner; Michel Gagner
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

4.  Tranexamic acid versus placebo to reduce perioperative blood transfusion in patients undergoing liver resection: protocol for the haemorrhage during liver resection tranexamic acid (HeLiX) randomised controlled trial.

Authors:  Paul Jack Karanicolas; Yulia Lin; Stuart McCluskey; Rachel Roke; Jordan Tarshis; Kevin E Thorpe; Chad G Ball; Prosanto Chaudhury; Sean P Cleary; Elijah Dixon; Gareth Eeson; Carol-Anne Moulton; Sulaiman Nanji; Geoff Porter; Leyo Ruo; Anton I Skaro; Melanie Tsang; Alice C Wei; Gordon Guyatt
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.